AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 68 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $20,000 | -47.4% | 31,275 | -44.4% | 0.00% | – |
| Q2 2019 | $38,000 | -78.8% | 56,200 | -74.3% | 0.00% | – |
| Q1 2019 | $179,000 | -60.7% | 218,789 | -23.1% | 0.00% | -100.0% |
| Q4 2018 | $455,000 | +810.0% | 284,645 | +717.8% | 0.00% | – |
| Q1 2015 | $50,000 | -93.0% | 34,805 | -95.9% | 0.00% | -100.0% |
| Q4 2014 | $711,000 | -22.7% | 845,751 | +2.0% | 0.00% | 0.0% |
| Q3 2014 | $920,000 | -51.2% | 829,210 | -19.5% | 0.00% | -66.7% |
| Q2 2014 | $1,886,000 | +14.0% | 1,030,292 | -6.9% | 0.00% | +50.0% |
| Q1 2014 | $1,655,000 | -2.8% | 1,106,682 | +19.6% | 0.00% | 0.0% |
| Q4 2013 | $1,702,000 | +1.1% | 925,254 | +13.7% | 0.00% | -33.3% |
| Q3 2013 | $1,684,000 | +69.2% | 813,645 | +104.4% | 0.00% | +50.0% |
| Q2 2013 | $995,000 | – | 398,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $1,884,000 | 100.00% |
| Prosight Management, LP | 1,057,690 | $2,951,000 | 2.17% |
| NEA Management Company, LLC | 16,362,694 | $45,652,000 | 1.89% |
| EMORY UNIVERSITY | 602,883 | $1,682,000 | 1.44% |
| New Leaf Venture Partners, L.L.C. | 964,520 | $2,691,000 | 1.26% |
| RA Capital Management | 5,062,759 | $14,125,000 | 1.18% |
| Avoro Capital Advisors LLC | 4,006,893 | $11,179,000 | 0.72% |
| 683 Capital Management, LLC | 2,500,000 | $6,975,000 | 0.59% |
| X-Square Capital, LLC | 199,345 | $557,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,627,000 | 0.43% |